Drug Profile
Ragweed allergy immunotherapy - Stallergenes Greer plc
Alternative Names: Ragweed pollen extract - Stallergenes Greer plc; Ragweed SLIT tablets - Stallergenes Greer plc; STAGR SAIL™ SLITLatest Information Update: 28 Aug 2019
Price :
$50
*
At a glance
- Originator Stallergenes SA
- Developer Stallergenes Greer plc
- Class Allergens; Antiallergics; Plant allergy immunotherapies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Seasonal allergic rhinitis
Most Recent Events
- 28 Aug 2019 No development reported - Phase-III for Seasonal allergic rhinitis in USA (Sublingual) (Stallergenes Greer's pipeline, August 2019)
- 30 Nov 2012 Clinical development is ongoing
- 26 Oct 2010 Stallergenes completes a phase I trial in Seasonal allergic rhinitis in Hungary